AVENTURA, Fla., Oct. 26, 2011 /PRNewswire/ -- ONE Bio, Corp. ("ONE" or the "Company") (OTC BB: ONBI), an innovative company utilizing green process manufacturing to produce raw chemicals and herbal extracts, natural and health supplements and organic products, today announced it has appointed BDO USA, LLP ("BDO") as its new independent auditor.
BDO has been engaged to perform the Company's (including its China and Canada subsidiaries) quarterly reviews and annual audit. With 41 offices in the United States, offices in China and over 1,000 BDO offices in more than 100 countries worldwide, BDO is uniquely positioned to provide to the Company the necessary SEC expertise and credibility.
Marius Silvasan, ONE's CEO, stated, "BDO's depth and breadth of knowledge and international expertise as a top auditing firm will provide further credibility to our financials particularly in view of recent market concerns over the filings for certain companies with operations in China. We are pleased to have BDO as our auditor and look forward to a successful working relationship. I would also like to take this opportunity to thank JSW our former auditor for their work and support."
About ONE Bio, Corp.
ONE Bio, Corp. ("ONE") (OTC BB: ONBI) (www.onehcorp.com), headquartered in Miami, FL, is an innovative company utilizing patented green process manufacturing to produce raw chemicals and herbal extracts, natural supplements and organic products. ONE is focused on the Asia Pacific region and the United States. Key products include widely recognized Solanesol, CoQ10, Resveratrol and 5-HTP, organic fertilizers, and organic bamboo health food and beverages. ONE has experienced solid organic growth driven by a robust demand for its products in China, Japan and the United States.
This press release includes statements that constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 (the "Reform Act"). ONE Bio, Corp. claims the protection of the safe-harbor for forward-looking statements contained in the Reform Act. These forward-looking statements are often characterized by the terms "may," "believes," "projects," "expects," or "anticipates," and do not reflect historical facts. Specific forward-looking statements contained in this press release include, but are not limited to: our successful integration of diversified growth companies, impact of the company's expansion plan, and new business development success, future financial results, development and acquisition of new product lines and services, the impact of competitive products or pricing from technological changes, the effect of economic conditions and other uncertainties. The forward-looking statements contained herein involve risks and uncertainties that could cause actual results to differ materially from the expectations contained in any such forward-looking statements. These risks include, but are not limited to: failure to manage operating expenses or integrate new companies and/or technologies, each of which could have a material impact on our business, our financial results, and the company's stock price. These risks and other factors are detailed in the Company's regular filings with the U.S. Securities and Exchange Commission. Most of these factors are difficult to predict accurately and are generally beyond the Company's control. Forward-looking statements speak only as to the date they are made and ONE Bio, Corp. does not undertake to update forward-looking statements to reflect circumstances or events that occur after the date the forward-looking statements are made.
Tel. + 786-288-3488
Investor Relations Contact:
Investor Relations & Corporate Communications
SOURCE ONE Bio, Corp.